🇺🇸 FDA
Patent

US 8481055

Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides

granted A61KA61K2039/55561A61K2039/57

Quick answer

US patent 8481055 (Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/55561, A61K2039/57, A61K31/711, A61K31/7125